Dr Hugo Turner
My current role is to establish and lead a health economics group within the Oxford University Clinical Research Unit, building in-house capacity to design and perform health economic analyses.
My research focuses on health economic analyses of infectious diseases in low and middle-income countries. I specialize and have extensive experience in performing costings of healthcare interventions, cost of illness analysis and cost-effectiveness analysis. I work on projects on a wide range of infectious diseases (including neglected tropical diseases, dengue, HCV, HPV, hospital-acquired infections, and tetanus). The goal of my research career is to use health economics to help optimise healthcare policy in low and middle-income countries.
Economic evaluation studies in the field of HIV/AIDS: bibliometric analysis on research development and scopes (GAPRESEARCH).
Tran BX. et al, (2019), BMC health services research, 19
Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmission.
Toor J. et al, (2019), Parasites & Vectors, 12
The direct-medical costs associated with interferon-based treatment for Hepatitis C in Vietnam
Nguyen HA. et al, (2019), Wellcome Open Research, 4, 129 - 129
Affordability of antimicrobials for animals and humans in Vietnam: A call to revise pricing policies.
Carrique-Mas J. et al, (2019), International journal of antimicrobial agents, 54, 269 - 270
The health and economic burden of lymphatic filariasis prior to mass drug administration programmes.
Mathew CG. et al, (2019), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America